GBS Inc. Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic…
NEW YORK, June 16, 2022 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point of care, today announced that…